NO943737L - 1,4-naftoquinonderivater med anti-protosoal og anti-parasittisk aktivitet - Google Patents

1,4-naftoquinonderivater med anti-protosoal og anti-parasittisk aktivitet

Info

Publication number
NO943737L
NO943737L NO943737A NO943737A NO943737L NO 943737 L NO943737 L NO 943737L NO 943737 A NO943737 A NO 943737A NO 943737 A NO943737 A NO 943737A NO 943737 L NO943737 L NO 943737L
Authority
NO
Norway
Prior art keywords
group
optionally substituted
group optionally
alkoxy
hydroxy
Prior art date
Application number
NO943737A
Other languages
English (en)
Norwegian (no)
Other versions
NO943737D0 (no
Inventor
Alan Thomas Hudson
Clive Leonard Yeates
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO943737D0 publication Critical patent/NO943737D0/no
Publication of NO943737L publication Critical patent/NO943737L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO943737A 1992-04-06 1994-10-05 1,4-naftoquinonderivater med anti-protosoal og anti-parasittisk aktivitet NO943737L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929207517A GB9207517D0 (en) 1992-04-06 1992-04-06 Heterocyclic compounds
PCT/GB1993/000708 WO1993020044A1 (fr) 1992-04-06 1993-04-05 Derives de 1,4 naphtoquinone, a activite anti-protozoaire et anti-parasitaire

Publications (2)

Publication Number Publication Date
NO943737D0 NO943737D0 (no) 1994-10-05
NO943737L true NO943737L (no) 1994-11-29

Family

ID=10713546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943737A NO943737L (no) 1992-04-06 1994-10-05 1,4-naftoquinonderivater med anti-protosoal og anti-parasittisk aktivitet

Country Status (16)

Country Link
EP (1) EP0634996A1 (fr)
JP (1) JPH07505388A (fr)
KR (1) KR950700874A (fr)
CN (1) CN1083048A (fr)
AU (1) AU3899293A (fr)
CA (1) CA2133744A1 (fr)
CZ (1) CZ242994A3 (fr)
FI (1) FI944657A (fr)
GB (1) GB9207517D0 (fr)
HU (1) HUT68937A (fr)
IL (1) IL105322A0 (fr)
MX (1) MX9301962A (fr)
NO (1) NO943737L (fr)
SK (1) SK120994A3 (fr)
WO (1) WO1993020044A1 (fr)
ZA (1) ZA932458B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013093937A2 (fr) * 2011-09-16 2013-06-27 Alkem Laboratories Ltd. Promédicament de ''3-(5-méthyl-2-oxo-l, 3-dioxol-4-yl) méthyloxy-2- trans-[(4-chlorophényl) cyclohexyl] [1,4]naphtaquinone"-atovaquone
MA45411A (fr) 2016-06-20 2019-04-24 Scripps Research Inst Compositions antimalariques et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
EP0362996B1 (fr) * 1988-08-16 1994-04-27 The Wellcome Foundation Limited Naphtoquinones pour le traitement et prophylaxe des infections de pneumocystis carinii

Also Published As

Publication number Publication date
HUT68937A (en) 1995-08-28
GB9207517D0 (en) 1992-05-20
ZA932458B (en) 1994-10-05
FI944657A (fi) 1994-12-02
WO1993020044A1 (fr) 1993-10-14
CN1083048A (zh) 1994-03-02
SK120994A3 (en) 1995-07-11
NO943737D0 (no) 1994-10-05
AU3899293A (en) 1993-11-08
EP0634996A1 (fr) 1995-01-25
JPH07505388A (ja) 1995-06-15
IL105322A0 (en) 1993-08-18
CZ242994A3 (en) 1995-06-14
KR950700874A (ko) 1995-02-20
HU9402850D0 (en) 1995-01-30
CA2133744A1 (fr) 1993-10-14
FI944657A0 (fi) 1994-10-05
MX9301962A (es) 1993-11-01

Similar Documents

Publication Publication Date Title
TR200000735T2 (tr) Benzamidoksim türevi, ara ürünler ve üretim yöntemleri.
DE68920654D1 (de) 4-Oxochinolin-3-carbonsäure-Derivate, ihre Herstellung und ihre Verwendung.
ES8505970A1 (es) Procedimiento para la produccion de nuevos derivados de n-(2-nitrofenil)-4-aminopirimidina.
ATE62686T1 (de) Neue 3-oxadiazol- und 3-carbonsaeure-betacarbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
DE3675733D1 (de) 3-vinyl- und 3-ethinyl-beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
NO943737L (no) 1,4-naftoquinonderivater med anti-protosoal og anti-parasittisk aktivitet
NO933170L (no) Heterocykliske forbindelser
ATE66226T1 (de) Tetrahydro-beta-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
ES456400A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ATE24487T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE206050T1 (de) Okulares hypotensium
HUP0001545A2 (hu) Karbonsavészterszármazékok, előállításuk és alkalmazásuk herbicid hatású piridazin-3-on-származékok előállítására
CA2009542A1 (fr) Guanidines cycliques comme antagonistes du calcium
NO963307L (no) Karbamoylmetylureaderivater
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
ATE19629T1 (de) N-substituierte derivate des tetrahydroisophthalimids.
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
NO923517L (no) Heterocykliske forbindelser
ES431300A1 (es) Un procedimiento de preparacion de un derivado de benzoxa- zol.
WO1999055156A3 (fr) Utilisation de derives d'iminotriazol comme agents phytosanitaires et nouveaux iminotriazols
NO951573L (no) Tiadiazinon-derivater
NO974759L (no) Cefalosporinpyridiniumderivater